• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

由树突状细胞和胸腺上皮细胞表达的DEC-205受体参与抗原加工。

The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing.

作者信息

Jiang W, Swiggard W J, Heufler C, Peng M, Mirza A, Steinman R M, Nussenzweig M C

机构信息

Laboratory of Molecular Immunology, Rockefeller University, New York, New York 10021, USA.

出版信息

Nature. 1995 May 11;375(6527):151-5. doi: 10.1038/375151a0.

DOI:10.1038/375151a0
PMID:7753172
Abstract

Dendritic cells and thymic epithelial cells perform important immunoregulatory functions by presenting antigens in the form of peptides bound to cell-surface major histocompatibility complex (MHC) molecules to T cells. Whereas B cells are known to present specific antigens efficiently through their surface immunoglobins, a comparable mechanism for the capture and efficient presentation of diverse antigens by dendritic cells and thymic epithelial cells has not previously been described. We show here that their antigen-presentation function is associated with the high-level expression of DEC-205, an integral membrane protein homologous to the macrophage mannose receptor and related receptors which are able to bind carbohydrates and mediate endocytosis. DEC-205 is rapidly taken up by means of coated pits and vesicles, and is delivered to a multivesicular endosomal compartment that resembles the MHC class II-containing vesicles implicated in antigen presentation. Rabbit antibodies that bind DEC-205 are presented to reactive T-cell hybridomas 100-fold more efficiently than rabbit antibodies that do not bind DEC-205. Thus DEC-205 is a novel endocytic receptor that can be used by dendritic cells and thymic epithelial cells to direct captured antigens from the extracellular space to a specialized antigen-processing compartment.

摘要

树突状细胞和胸腺上皮细胞通过将与细胞表面主要组织相容性复合体(MHC)分子结合的肽形式的抗原呈递给T细胞,来执行重要的免疫调节功能。虽然已知B细胞通过其表面免疫球蛋白有效地呈递特定抗原,但此前尚未描述树突状细胞和胸腺上皮细胞捕获和有效呈递多种抗原的类似机制。我们在此表明,它们的抗原呈递功能与DEC-205的高水平表达相关,DEC-205是一种整合膜蛋白,与巨噬细胞甘露糖受体及相关受体同源,这些受体能够结合碳水化合物并介导内吞作用。DEC-205通过有被小窝和小泡迅速被摄取,并被递送至一种多泡内体区室,该区域类似于参与抗原呈递的含MHC II类分子的小泡。与不结合DEC-205的兔抗体相比,结合DEC-205的兔抗体被呈递给反应性T细胞杂交瘤的效率要高100倍。因此,DEC-205是一种新型的内吞受体,树突状细胞和胸腺上皮细胞可利用它将从细胞外空间捕获的抗原导向一个专门的抗原加工区室。

相似文献

1
The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing.由树突状细胞和胸腺上皮细胞表达的DEC-205受体参与抗原加工。
Nature. 1995 May 11;375(6527):151-5. doi: 10.1038/375151a0.
2
The dendritic cell receptor for endocytosis, DEC-205, can recycle and enhance antigen presentation via major histocompatibility complex class II-positive lysosomal compartments.用于内吞作用的树突状细胞受体DEC-205可循环利用,并通过主要组织相容性复合体II类阳性溶酶体区室增强抗原呈递。
J Cell Biol. 2000 Oct 30;151(3):673-84. doi: 10.1083/jcb.151.3.673.
3
[The DEC-205 receptor expressed by dendritic cells and thymic epithelial cells is implicated in antigen processing].树突状细胞和胸腺上皮细胞表达的DEC-205受体与抗原处理有关。
Nephrologie. 1995;16(5):381.
4
Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network.树突状细胞类型,即哺乳动物胸腺微环境中的辅助细胞。树突状神经-内分泌-免疫细胞网络中的抗原呈递。
In Vivo. 1997 Jul-Aug;11(4):351-70.
5
Robust T-cell stimulation by Epstein-Barr virus-transformed B cells after antigen targeting to DEC-205.经 DEC-205 靶向抗原后,Epstein-Barr 病毒转化的 B 细胞可实现对 T 细胞的稳健刺激。
Blood. 2013 Feb 28;121(9):1584-94. doi: 10.1182/blood-2012-08-450775. Epub 2013 Jan 7.
6
Expression of human DEC-205 (CD205) multilectin receptor on leukocytes.人DEC-205(CD205)多凝集素受体在白细胞上的表达。
Int Immunol. 2006 Jun;18(6):857-69. doi: 10.1093/intimm/dxl022. Epub 2006 Mar 31.
7
Mannose receptor-mediated uptake of antigens strongly enhances HLA class II-restricted antigen presentation by cultured dendritic cells.
Eur J Immunol. 1997 Sep;27(9):2426-35. doi: 10.1002/eji.1830270942.
8
Tolerogenic dendritic cells.耐受性树突状细胞
Annu Rev Immunol. 2003;21:685-711. doi: 10.1146/annurev.immunol.21.120601.141040. Epub 2001 Dec 19.
9
DEC-205, a 205-kDa protein abundant on mouse dendritic cells and thymic epithelium that is detected by the monoclonal antibody NLDC-145: purification, characterization, and N-terminal amino acid sequence.
Cell Immunol. 1995 Oct 15;165(2):302-11. doi: 10.1006/cimm.1995.1218.
10
Altered expression and endocytic function of CD205 in human dendritic cells, and detection of a CD205-DCL-1 fusion protein upon dendritic cell maturation.人树突状细胞中CD205的表达及内吞功能改变,以及树突状细胞成熟时CD205-DCL-1融合蛋白的检测。
Immunology. 2007 Mar;120(3):362-71. doi: 10.1111/j.1365-2567.2006.02512.x. Epub 2006 Dec 8.

引用本文的文献

1
Dendritic cell targeting in lymph nodes with modular adapters boosts HAdV5 and HC-HAdV5 tumor vaccination by co-secretion of IL-2v and IL-21.使用模块化衔接子靶向淋巴结中的树突状细胞,通过共分泌IL-2v和IL-21增强腺病毒5型和HC-腺病毒5型肿瘤疫苗接种效果。
Mol Ther Oncol. 2025 Apr 14;33(2):200984. doi: 10.1016/j.omton.2025.200984. eCollection 2025 Jun 18.
2
Neutrophils in the Bone Marrow Express DEC205, Guiding Their Migration to Inflamed Tissues.骨髓中的中性粒细胞表达DEC205,引导其迁移至炎症组织。
Immunology. 2025 Oct;176(2):237-249. doi: 10.1111/imm.13958. Epub 2025 Jun 4.
3
Clonal Hematopoiesis and Solid Cancers.
克隆性造血与实体癌
Cancer Sci. 2025 Aug;116(8):2055-2063. doi: 10.1111/cas.70097. Epub 2025 May 19.
4
The Cellular and Molecular Characteristics of Postnatal Human Thymus Stromal Stem Cells.产后人类胸腺基质干细胞的细胞和分子特征
Biomedicines. 2025 Apr 21;13(4):1004. doi: 10.3390/biomedicines13041004.
5
Antibody-Based Antigen Delivery to Dendritic Cells as a Vaccination Strategy Against Ebola Virus Disease.基于抗体的抗原递送至树突状细胞作为抗埃博拉病毒病的疫苗接种策略。
J Infect Dis. 2025 Apr 15;231(4):e615-e625. doi: 10.1093/infdis/jiae613.
6
Mannose and Lactobionic Acid in Nasal Vaccination: Enhancing Antigen Delivery via C-Type Lectin Receptors.鼻腔接种中的甘露糖和乳糖酸:通过C型凝集素受体增强抗原递送
Pharmaceutics. 2024 Oct 8;16(10):1308. doi: 10.3390/pharmaceutics16101308.
7
Advances in targeted delivery of mRNA into immune cells for enhanced cancer therapy.mRNA 靶向递送至免疫细胞以增强癌症治疗的进展。
Theranostics. 2024 Sep 3;14(14):5528-5550. doi: 10.7150/thno.93745. eCollection 2024.
8
Adjuvants for cancer mRNA vaccines in the era of nanotechnology: strategies, applications, and future directions.纳米技术时代的癌症 mRNA 疫苗佐剂:策略、应用和未来方向。
J Nanobiotechnology. 2024 Jun 2;22(1):308. doi: 10.1186/s12951-024-02590-6.
9
Targeting lymph nodes for enhanced cancer vaccination: From nanotechnology to tissue engineering.靶向淋巴结以增强癌症疫苗接种:从纳米技术到组织工程
Mater Today Bio. 2024 Apr 26;26:101068. doi: 10.1016/j.mtbio.2024.101068. eCollection 2024 Jun.
10
Differential Immune Response Patterns Induced by Anionic and Cationic Lipid Adjuvants in Intranasal Anti-Influenza Immunization.阴离子和阳离子脂质佐剂在鼻内抗流感免疫中诱导的差异免疫反应模式
Vaccines (Basel). 2024 Mar 18;12(3):320. doi: 10.3390/vaccines12030320.